Reaction equation
[CH3:1][CH2:2][O:3][C:4]([C:6]1([CH3:14])[NH:10][CH:9]([C:11]([OH:13])=[O:12])[CH2:8][S:7]1)=[O:5].N[C@@H:16]([C:19](O)=[O:20])CS>>[CH3:1][CH2:2][O:3][C:4]([C:6]1([CH3:14])[N:10]([C:19](=[O:20])[CH3:16])[CH:9]([C:11]([OH:13])=[O:12])[CH2:8][S:7]1)=[O:5]Participants
3
Procedure
By a method similar to that in Synthetic Example 7 except for the use of 2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester synthesized from D-cysteine by a method similar to that in Reference Example 2, N-acetyl-2-methylthiazolidine-2,4-dicarboxylic acid 2-ethyl ester was obtained (with the ratio of cis form:trans form of about 43:57 as confirmed by NMR).
Sources & evidence
- ORD record
- ord-d299629c64024410895b804341dc4ff2
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09212154B2
Linked notes
Loading…